Industry News

DIGITIMES Asia: Tesla and Nvidia set to go head-to-head in high-end autonomous driving

Nuying Huang, Taipei; Jack Wu, DIGITIMES Asia Wednesday 31 July 2024 TAIPEI, July 31, 2024 /PRNewswire/ -- In the realm of end-to-end advanced autonomous driving solutions, both Nvidia and Tesla are dominant forces. Credit: AFP Their...

2024-07-31 15:30 1457

Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024

CHICAGO, July 31, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its innovative IVD total solutions at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), fromJuly 28 to August 1 in Chicago. Committed to supporting local partners, we del...

2024-07-31 14:42 1243

Global Times: Iconic 'lighthouse factories' shed lights on digital transformation of China's manufacturing industry

BEIJING, July 31, 2024 /PRNewswire/ -- As China has been accelerating a nationwide industrial upgrade and cultivating new quality productive forces to support economic recovery, the country is prioritizing smart manufacturing and technology transformation to drive the automation and digitalizatio...

2024-07-31 14:02 1544

ITE HCMC 2024 AIMS TO ELEVATE VIETNAM'S TOURISM BY LEVERAGING SUSTAINABILITY AND COLLABORATION

HO CHI MINH CITY, Vietnam, July 31, 2024 /PRNewswire/ -- The 18th International Travel Expo Ho Chi Minh City 2024 (ITE HCMC 2024), to be held onSeptember 5 - 7, 2024, promises to provide travel and hospitality businesses with unparalleled access to innovative product ideas and business models to ...

2024-07-31 12:14 1619

FDA Grants Orphan Drug Designation (ODD) Status to Zymedi's ZMA001 for Pulmonary Arterial Hypertension

INCHEON, South Korea, July 30, 2024 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that its first-in-class antibody treatment ZMA001, currently in development for pulmonary arterial hypertension (PAH), has been designated as an Orphan Drug by the U.S. Food and Drug Administration (FDA). Pul...

2024-07-31 08:00 1653

Golden Heaven Group Holdings Ltd. Announces Financial Results for the First Half of Fiscal Year 2024

NANPING, China, July 30, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced its unaudited financial results for the six months ended March 31, 2024 ("First Half 2024"). First Half 2024 Fina...

2024-07-31 04:05 3553

Attrisys Announces Official Launch: Revolutionizing Amazon Sales Through Advanced Analytics

COLORADO SPRINGS, Colo., July 30, 2024 /PRNewswire/ -- Attrisys is excited to announce its official launch in Q3 2024. Founded by a team of former Google and Amazon employees, Attrisys is poised to transform the Amazon sales landscape for businesses acrossNorth America and beyond. With a focus on...

2024-07-30 23:00 1403

Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics

SUZHOU, China, July 30, 2024 /PRNewswire/ -- On July 29, 2024, Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Biotech"). Both sides will combine their respective strengths in the field of gene...

2024-07-30 22:00 2393

Sunseeker showcased Latest Innovations at Lawn & Landscape Technology Conference 2024

ATLANTA, July 30, 2024 /PRNewswire/ -- Sunseeker , a world-leading innovative company of high-tech equipment, specializing in robotic lawn mowers and lithium battery-powered garden tools, has featured its latestSunseeker Orion X7 and 60 Volt commercial series at t...

2024-07-30 22:00 1493

Puyi Fund of Highest Performances Holdings Inc.(NASDAQ: HPH) Wins "2024 Outstanding Wealth Management Award"

GUANGZHOU, China, July 30, 2024 /PRNewswire/ -- The 13th CFS Finance Summit and Amazing 2024 Innovative Entrepreneur Festival concluded successfully inBeijing. Fanhua Puyi Fund Distribution Co., Ltd., ("Puyi Fund" or the "Company"), a subsidiary of Highest Performances Holdings Inc.(NASDAQ: HPH) ...

2024-07-30 21:35 3949

Seadronix Disrupts Maritime Technology with Groundbreaking AI Model

SEOUL, South Korea, July 30, 2024 /PRNewswire/ -- Seadronix, a leader in AI-enabled autonomous ship navigation solutions, has announced the release of a groundbreaking white paper on artificial intelligence (AI) for marine object recognition. This innovative research introduces the VaDA (Vertical...

2024-07-30 21:00 2077

POP MART: Unveiling an Innovative Retail Experience at the Louvre

BEIJING, July 30, 2024 /PRNewswire/ -- POP MART proudly announced the grand opening of its new store in the Louvre, a historic first for this iconic museum , onJuly 27, 2024. Strategically located in the Carrousel du Louvre, near the museum's secondary entrance and the glass pyramid, the store uni...

2024-07-30 21:00 4088

Hugging Every Fun Thought! Haivivi Unveils the World's First AIGC Toy, BubblePal

SHENZHEN, China, July 30, 2024 /PRNewswire/ -- With the rapid advancement of AI technology, toys, one of humanity's greatest inventions driven by natural instincts, are now encountering new development opportunities. On June 25th, emerging AI toy innovator Haivivi officially launched the world's...

2024-07-30 18:01 1349

Global Times: World Heritage Site Beijing Central Axis: 'Masterpiece' with unique Eastern charm

BEIJING, July 30, 2024 /PRNewswire/ -- Chinese people love symmetry, which involves elements mirrored along a central axis, creating a balanced and harmonious composition that is visually appealing as well. The Central Axis is very important to Chinese as balance and harmony are key elements in C...

2024-07-30 17:56 2015

Baird Medical Announces Engagement and Education Program for the Development of Thyroid Microwave Ablation Technology

FRISCO, Texas, July 30, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina and the United States, today announced a cross-market engagement and education program designed at fostering both kno...

2024-07-30 17:00 1692

The Circulate Initiative issues call to action to financial community as investment gap widens to meet targets to tackle plastic pollution

SINGAPORE, July 30, 2024 /PRNewswire/ -- The Circulate Initiative is calling for greater investment into tackling plastic pollution, as new data reveals an average ofUS$ 32 billion a year of private investment went to plastics circularity between 2018 and 2023, far below theone trillion dollars n...

2024-07-30 17:00 1561

Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors

SHENZHEN, China, July 30, 2024 /PRNewswire/ -- Shenzhen Synthetica Pioneering Co., Ltd. (Synthetica), a biotech startup specializing in synthetic biology for engineering novel living bacterial therapeutics, has recently closed a Series A funding round, led by Boehringer Ingelheim Venture Fund and...

2024-07-30 14:00 1614

Toss Securities Expands Global Footprint with Establishment of US Office

* Toss Securities establishes its first global office in the U.S., aiming to expand its global presence * Kyungsoo (Peter) Kim, the current Head of Finance, will be appointed as the CEO for U.S. entity * Seungyeon Kim, CEO of Toss Securities says "The U.S. office will significantly accelera...

2024-07-30 10:00 1687

SK hynix Enhances Leadership in Graphics Memory With Introduction of Industry's Best GDDR7

* Industry's best-performing graphics memory with improvement of 60% in speed, 50% in power efficiency to be mass produced in 3Q24 * GDDR7 processes data equivalent to 300 Full-HD movies in a second when combined with high-end graphics card * AI, high-performance computing, autonomous vehicl...

2024-07-30 08:00 1645

Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical Study of BBT-877 for the Treatment of Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea, July 29, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based inSouth Korea developing novel drugs for fibrosis and cancer, today announced that patient participant enrollment has been completed in the Phase 2 clinical study of BBT-...

2024-07-30 06:00 1537